Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-18 · accession 0001540354-24-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-18 | NMTC | Rosa David A | CEO, Pres, Dir | A - Grant | $0.00 | +663.5K | 1.19M | +126% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-18 | A | A | 663,497 | $0.00 | 1,188,987 | D | — | — | (F1) Represents a grant of restricted stock units, which vest as to 25% of the shares on each of the first, second, third and fourth anniversaries of the grant date. |